Researchers analyzed the outcomes of 199 COVID-19 patients in the emergency and intensive care units across three Columbian hospitals from August 2020 to January 2021 and followed them through Feb. 10, 2021. About half were given high-flow oxygen and half were assigned conventional oxygen therapy.
About 34.3 percent of patients receiving high-flow oxygen were intubated, compared to 51 percent of those on conventional oxygen therapy. The median time to recover among the high-flow oxygen cohort was lower at 11 days compared to 14 days for patients receiving conventional oxygen therapy.
“Among patients with severe COVID-19, use of high-flow oxygen through a nasal cannula significantly decreased need for mechanical ventilation support and time to clinical recovery compared with conventional low-flow oxygen therapy,” researchers concluded.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.